Compare BMY & CB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMY | CB |
|---|---|---|
| Founded | 1887 | 1985 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.0B | 106.9B |
| IPO Year | N/A | 1993 |
| Metric | BMY | CB |
|---|---|---|
| Price | $50.82 | $302.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 17 |
| Target Price | $55.58 | ★ $309.06 |
| AVG Volume (30 Days) | ★ 15.1M | 1.5M |
| Earning Date | 10-30-2025 | 01-27-2026 |
| Dividend Yield | ★ 4.80% | 1.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.97 | ★ 23.94 |
| Revenue | $48,034,000,000.00 | ★ $58,842,000,000.00 |
| Revenue This Year | $0.23 | N/A |
| Revenue Next Year | N/A | $5.28 |
| P/E Ratio | $17.39 | ★ $12.42 |
| Revenue Growth | 1.26 | ★ 7.43 |
| 52 Week Low | $42.52 | $252.16 |
| 52 Week High | $63.33 | $306.91 |
| Indicator | BMY | CB |
|---|---|---|
| Relative Strength Index (RSI) | 63.47 | 69.43 |
| Support Level | $48.22 | $291.75 |
| Resistance Level | $52.51 | $297.75 |
| Average True Range (ATR) | 1.13 | 3.94 |
| MACD | 0.29 | -0.17 |
| Stochastic Oscillator | 77.92 | 97.64 |
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination made the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.